A freeze-dried injectable form of flurbiprofen: Development and optimisation using response surface methodology

International Journal of Pharmaceutics

Volumn 161, Issue 1, 1998, Pages 87-94

  Kagkadis, K A ^a   Rekkas, D M ^a   Dallas, P P ^a   Choulis, N H ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

2 Hydroxypropyl cyclodextrin; Experimental design; Flurbiprofen; Freeze dried; Injectable; Response surface methodology

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; FLURBIPROFEN;

ARTICLE; DRUG SOLUBILITY; DRUG SYNTHESIS; FREEZE DRYING; INJECTION; METHODOLOGY; PRIORITY JOURNAL;

EID: 0032498519     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00332-3     Document Type: Article

References (8)

1. Bolton, S., 1990. Optimization in Pharmaceutical Statistics. Marcel Dekker, New York, pp. 421-452.
2. Higuchi, T., Connors, K.A., 1965. Phase solubility techniques. In: Reilley, C.N. (Ed.), Advances in Analytical Chemistry and Instrumentation. Interscience, New York, p. 132.
3. Kagkadis K.A., Rekkas D.M., Dallas P.P., Choulis N.H. A freeze-dried injectable form of Ibuprofen: development and optimisation using response surface methodology. PDA J. Pharm. Sci. Technol. 50:1996;317-323.
4. Loftsson T., Kaminski J.J., Bodor N. Improved delivery through biological membranes. VIII. Design, synthesis and in vivo testing of true prodrugs of Aspirin. J. Pharm. Sci. 70:1981;743-749.
5. Loftsson T., Fridriksdottir H., Olatsdottir B.J., Gudmundsson O. Solubilization and stabilization of drugs through cyclodextrin complexation. Acta Pharm. Nord. 3:1991;215-217.
6. Nixon, J.R., Harris, M.S., 1986. Coacervate techniques for the preparation of microcapsules of possible pharmaceutical application. In: Gorrod, J.W., Gibson, G.G., Mitchard, M. (Eds.), Development of Drugs and Modern Medicines. Ellis Horwood, Chichester, UK, pp. 425-434.
7. Szejtli J. Cyclodextrins: properties and applications. Drug Invest. 2(Suppl. 4):1990;11-21.
8. Szejtli J. Cyelodextrins in drug formulations: Part I. Pharm. Technol. 15:1991;36-44.